Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000827871-14-000010
Filing Date
2014-05-15
Accepted
2014-05-15 11:24:56
Documents
10
Period of Report
2014-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q egrx_q2x2014.htm 10-Q 1104415
2 EXHIBIT 31.1 exhibit311.htm EX-31.1 11108
3 EXHIBIT 31.2 exhibit312.htm EX-31.2 11285
4 EXHIBIT 32.1 exhibit321.htm EX-32.1 5783
  Complete submission text file 0000827871-14-000010.txt   5500057

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT egrx-20140331.xml EX-101.INS 713100
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT egrx-20140331.xsd EX-101.SCH 38753
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT egrx-20140331_cal.xml EX-101.CAL 46201
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT egrx-20140331_def.xml EX-101.DEF 229839
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT egrx-20140331_lab.xml EX-101.LAB 480682
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT egrx-20140331_pre.xml EX-101.PRE 285960
Mailing Address 50 TICE BOULEVARD, SUITE 315 WOODCLIFF LAKE NJ 07677
Business Address 50 TICE BOULEVARD, SUITE 315 WOODCLIFF LAKE NJ 07677 201-326-5300
EAGLE PHARMACEUTICALS, INC. (Filer) CIK: 0000827871 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 0930
Type: 10-Q | Act: 34 | File No.: 001-36306 | Film No.: 14844832
SIC: 2834 Pharmaceutical Preparations